98%
921
2 minutes
20
Purpose: Uro-Dynamic MRI was used to non-invasively quantify bladder biomechanics, characterizing the fundamental relationship between bladder wall surface area and bladder volume during voiding.
Methods: Differential Subsampling with Cartesian Ordering MRI sequence was used to acquire multiple volumetric bladder images during the voiding in five normal male subjects. Images were imported into MIMICS. Bladder volume and bladder wall surface area were obtained using threshold-based image segmentation and the main axes of bladder wall deformation were measured/tracked throughout voiding. Linear anatomical measurements yielded bladder volume estimation using a generalized ellipsoid approximation and facilitated direct comparison with the metrics obtained from the 3D renderings.
Results: Ellipsoid volume approximation showed high agreement with volume from 3D renderings; however, this agreement does not hold for flow rates derived from both approaches. Analysis of changes in volume and surface area from 3D renderings show bladder deformation that varies throughout voiding, behaving closer to an idealized spherical bladder past the point of maximum flow. Further analysis suggests an asymmetrical and nonconstant change of bladder dimensions in relation to changes in bladder volume, and a generalized concentric contraction of the bladder wall past maximum flow during the voiding event.
Conclusion: Uro-Dynamic MRI allowed time-resolved analysis of the relationship between changes in anatomy-based measurements, volume and surface area of the bladder. This methodology highlights the use of Uro-Dynamic MRI as a powerful tool to comprehensively extract anatomical information of the bladder and correlate this information with novel Noninvasive metrics to evaluate patient specific biomechanics.
Clinical Trial Registration: The patients recruited for this study and data collected for this manuscript are not part of a clinical trial.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/nau.70140 | DOI Listing |
Eur Spine J
September 2025
Department of Spine Surgery, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Purpose: This study aimed to investigate the relationship between tissue bridges and bladder and bowel outcomes in chronic cervical spinal cord injury (SCI).
Methods: Between July 2020 and January 2024, 44 patients with chronic cervical SCI were retrospectively included in this cross-sectional study at a specialized SCI center. Lesion severity was assessed by tissue bridges, lesion length, lesion width, and lesion area.
Nat Rev Urol
September 2025
Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Low-grade non-muscle invasive bladder cancer is a specific category of bladder cancer with a favourable prognosis; however, its management presents several challenges. The risk of stage progression is very low, but approximately half of patients will experience recurrence within the first 5 years after diagnosis. This high propensity for recurrence, coupled with the threat of progression, mandates ongoing surveillance.
View Article and Find Full Text PDFNat Commun
September 2025
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
With the approval of the antibody-drug conjugate enfortumab vedotin (EV), NECTIN4 has emerged as a bona fide therapeutic target in urothelial carcinoma (UC). Here, we report the development of a NECTIN4-directed chimeric antigen receptor (CAR) T cell, which exhibits reactivity across cells expressing a range of endogenous NECTIN4, with enhanced activity in high expressors. We demonstrate that the PPARγ pathway, critical for luminal differentiation, transcriptionally controls NECTIN4, and that the PPARγ agonist rosiglitazone primes and augments NECTIN4 expression, thereby increasing sensitivity to NECTIN4-CAR T cell-mediated killing.
View Article and Find Full Text PDFUrol Oncol
September 2025
Nutritional, Genes and Human Disease Laboratory, Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh. Electronic address:
Background: Understanding the mutational landscape is critical for elucidating the molecular mechanisms driving cancer progression. This study aimed to profile somatic mutations in bladder cancer patients (N=7) from Bangladesh to provide insights into the genetic alterations underlying this malignancy.
Methods: We performed targeted sequencing of 50 oncogenes and tumor suppressor genes using the Ion AmpliSeq Cancer Hotspot Panel v2 on tumor and matched blood samples from seven bladder cancer patients.
Eur J Med Chem
September 2025
Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutical Sciences, Health Science Center, Hunan Normal University, Changsha, 410013, Hunan, China. Electronic address: